As per the earnings report commentary net product sales of DAYBUE were $96.7 million for the fourth quarter of 2024- an increase of just 11% as compared to $87.1 million for the fourth quarter of 2023.This is far less captivating than the quoted 97% increase reported for the full year 2023/2024 comparison.This 12 month time frame is probably more meaningful as it helps to smooth any unexpected discrepancies in the quarter by quarter assessments of progress and helps to explain the lack of patient numbers commentary from both parties involved.
Kens
As per the earnings report commentary net product sales of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |